Ayman El-Kadi - Publications

Affiliations: 
University of Alberta, Edmonton, Alberta, Canada 
Area:
Pharmaceutical Chemistry, Physiology Biology
Website:
https://www.ualberta.ca/pharmacy/about-us/contact-us-and-people/people/ayman-el-kadi

127 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 El-Mahrouk SR, El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. Dimethylmonothioarsinic acid (DMMTA) differentially modulates the expression of AHR-regulated cytochrome P450 1A enzymes in vivo and in vitro. Toxicology Letters. 394: 32-45. PMID 38403205 DOI: 10.1016/j.toxlet.2024.02.007  0.51
2024 Alqahtani MA, El-Ghiaty MA, El-Mahrouk SR, El-Kadi AOS. Differential Modulatory Effects of Methylmercury (MeHg) on Ahr-regulated Genes in Extrahepatic Tissues of C57BL/6 Mice. Biological Trace Element Research. PMID 38197905 DOI: 10.1007/s12011-023-04050-y  0.513
2023 Helal SA, Gerges SH, El-Kadi AOS. Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids. Drug Metabolism Reviews. 56: 31-45. PMID 38358327 DOI: 10.1080/03602532.2023.2284110  0.315
2023 Hidayat R, El-Ghiaty MA, Shoieb SM, Alqahtani MA, El-Kadi AOS. The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells. European Journal of Drug Metabolism and Pharmacokinetics. 48: 709-722. PMID 37815672 DOI: 10.1007/s13318-023-00857-1  0.357
2023 Alqahtani MA, El-Ghiaty MA, El-Mahrouk SR, El-Kadi AOS. Methylmercury (MeHg) transcriptionally regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) in Hepa-1c1c7 cells. Current Research in Toxicology. 5: 100126. PMID 37808441 DOI: 10.1016/j.crtox.2023.100126  0.429
2023 Hidayat R, Shoieb SM, Mosa FES, Barakat K, Brocks DR, Isse FA, Gerges SH, El-Kadi AOS. 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism. Molecular and Cellular Biochemistry. PMID 37436655 DOI: 10.1007/s11010-023-04801-4  0.381
2023 El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. Arsenic trioxide (ATO) up-regulates cytochrome P450 1A (CYP1A) enzymes in murine hepatoma Hepa-1c1c7 cell line. Environmental Toxicology and Pharmacology. 101: 104214. PMID 37423394 DOI: 10.1016/j.etap.2023.104214  0.375
2023 Isse FA, Alammari AH, El-Sherbeni AA, El-Kadi AOS. 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners. Prostaglandins & Other Lipid Mediators. 168: 106749. PMID 37244564 DOI: 10.1016/j.prostaglandins.2023.106749  0.412
2023 Alammari AH, Gerges SH, Isse FA, El-Kadi AOS. 6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 51: 833-843. PMID 37185150 DOI: 10.1124/dmd.123.001267  0.451
2023 El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. Modulation of cytochrome P450 1A (CYP1A) enzymes by monomethylmonothioarsonic acid (MMMTA) in vivo and in vitro. Chemico-Biological Interactions. 376: 110447. PMID 36893905 DOI: 10.1016/j.cbi.2023.110447  0.475
2022 Alqahtani MA, El-Ghiaty MA, El-Kadi AOS. Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro. Journal of Biochemical and Molecular Toxicology. e23243. PMID 36245390 DOI: 10.1002/jbt.23243  0.452
2022 Gerges SH, El-Kadi AOS. . Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 36116791 DOI: 10.1124/dmd.122.000915  0.323
2022 El-Ghiaty MA, Alqahtani MA, El-Kadi AOS. Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: A role of heme oxygenase 1. Chemico-Biological Interactions. 364: 110049. PMID 35872050 DOI: 10.1016/j.cbi.2022.110049  0.415
2022 Shoieb SM, Alammari AH, Levasseur J, Silver H, Dyck JRB, El-Kadi AOS. Ameliorative Role of Fluconazole against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats. Journal of Cardiovascular Pharmacology. PMID 35266922 DOI: 10.1097/FJC.0000000000001258  0.376
2021 Shoieb SM, Dakarapu R, Falck JR, El-Kadi AOS. Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1. European Journal of Drug Metabolism and Pharmacokinetics. PMID 34235626 DOI: 10.1007/s13318-021-00699-9  0.33
2020 Shoieb SM, El-Kadi AOS. Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites. Molecular and Cellular Biochemistry. PMID 32533462 DOI: 10.1007/s11010-020-03777-9  0.352
2020 Alammari AH, Shoieb SM, Maayah ZH, El-Kadi AOS. Fluconazole Represses Cytochrome P450 1B1 and its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy. Journal of Pharmaceutical Sciences. PMID 32240690 DOI: 10.1016/j.xphs.2020.03.016  0.383
2019 Al Nebaihi HM, Al Batran R, Ussher JR, Maayah ZH, El-Kadi AOS, Brocks DR. Dietary-induced obesity, hepatic cytochrome P450 and lidocaine metabolism: Comparative effects of high-fat diets in mice and rats and reversibility of effects with normalization of diet. Journal of Pharmaceutical Sciences. PMID 31733268 DOI: 10.1016/j.xphs.2019.11.007  0.317
2018 Shoieb SM, El-Sherbeni AA, El-Kadi AOS. Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states. Chemico-Biological Interactions. 299: 140-150. PMID 30543782 DOI: 10.1016/j.cbi.2018.12.004  0.324
2018 Matsumura N, Takahara S, Maayah ZH, Parajuli N, Byrne NJ, Shoieb SM, Soltys CM, Beker DL, Masson G, El-Kadi AOS, Dyck JRB. Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites. Journal of Molecular and Cellular Cardiology. PMID 30381233 DOI: 10.1016/j.yjmcc.2018.10.023  0.337
2018 Shoieb SM, El-Kadi AOS. S-Enantiomer of 19-Hydroxyeicosatetraenoic Acid Preferentially Protects Against Angiotensin II-Induced Cardiac Hypertrophy. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 29880629 DOI: 10.1124/dmd.118.082073  0.323
2018 Maayah ZH, Levasseur J, Siva Piragasam R, Abdelhamid G, Dyck JRB, Fahlman RP, Siraki AG, El-Kadi AOS. 2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy. Scientific Reports. 8: 2780. PMID 29426916 DOI: 10.1038/S41598-018-20613-9  0.353
2017 Maayah ZH, Abdelhamid G, Elshenawy OH, El-Sherbeni AA, Althurwi HN, McGinn E, Dawood D, Alammari AH, El-Kadi AOS. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity. Cardiovascular Toxicology. PMID 29196978 DOI: 10.1007/s12012-017-9437-8  0.5
2017 Alrushaid S, Zhao Y, Sayre CL, Maayah ZH, Laird Forrest M, Senadheera SN, Chaboyer K, Anderson HD, El-Kadi AOS, Davies NM. Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative. Drug Delivery and Translational Research. PMID 28462502 DOI: 10.1007/S13346-017-0379-2  0.323
2017 Elkhatali S, Maayah ZH, El-Sherbeni AA, Elshenawy OH, Abdelhamid G, Shoieb SM, El-Kadi AOS. Inhibition of Mid-chain HETEs Protects Against Angiotensin II-Induced Cardiac Hypertrophy. Journal of Cardiovascular Pharmacology. PMID 28437282 DOI: 10.1097/FJC.0000000000000494  0.322
2017 Maayah ZH, Althurwi HN, El-Sherbeni AA, Abdelhamid G, Siraki AG, El-Kadi AO. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol. Molecular and Cellular Biochemistry. PMID 28251434 DOI: 10.1007/s11010-017-2943-y  0.42
2017 Elshenawy OH, Abdelhamid G, Soshilov AA, Denison MS, El-Kadi AO. DOWN-REGULATION OF CYTOCHROME P450 1A1 BY MONOMETHYLARSONOUS ACID IN HUMAN HEPG2 CELLS. Toxicology Letters. PMID 28189647 DOI: 10.1016/J.Toxlet.2017.02.012  0.417
2017 Elshenawy OH, Abdelhamid G, Althurwi HN, El-Kadi AO. Dimethylarsinic acid modulates the aryl hydrocarbon receptor regulated genes in C57BL/6 mice: in vivo study. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-36. PMID 28134025 DOI: 10.1080/00498254.2017.1289423  0.469
2016 Gabr RQ, El-Sherbeni AA, Ben-Eltriki M, El-Kadi AO, Brocks DR. Pharmacokinetics of metformin in the rat: Assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea. Canadian Journal of Physiology and Pharmacology. PMID 28177686 DOI: 10.1139/cjpp-2016-0329  0.328
2016 El-Sherbeni AA, El-Kadi AO. Microsomal Cytochrome P450 as a Target for Drug Discovery and Repurposing. Drug Metabolism Reviews. 1-40. PMID 27819488 DOI: 10.1080/03602532.2016.1257021  0.302
2016 El-Sherbeni AA, El-Kadi AO. Repurposing Resveratrol and Fluconazole To Modulate Human Cytochrome P450-Mediated Arachidonic Acid Metabolism. Molecular Pharmaceutics. 13: 1278-88. PMID 26918316 DOI: 10.1021/acs.molpharmaceut.5b00873  0.36
2016 Anwar-Mohamed A, El-Sherbeni AA, Hamdy DA, Korashy HM, Brocks DR, El-Kadi AO. Ketoconazole Stereoisomers Differentially Induce Cytochrome P450 1A1 Between Human Hepatoma HepG2 and Mouse Hepatoma Hepa1c1c7 Cells. Journal of Pharmaceutical Sciences. 105: 1318-26. PMID 26886340 DOI: 10.1016/j.xphs.2015.12.009  0.302
2016 Maayah ZH, Althurwi HN, Abdelhamid G, Lesyk G, Jurasz P, El-Kadi AO. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism. Pharmacological Research. 105: 28-43. PMID 26772815 DOI: 10.1016/j.phrs.2015.12.016  0.342
2016 Maayah ZH, El-Kadi AO. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy. Archives of Toxicology. 90: 119-36. PMID 26525395 DOI: 10.1007/s00204-015-1620-8  0.314
2016 Maayah ZH, El-Kadi AO. 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-κB-dependent mechanism. Archives of Toxicology. 90: 359-73. PMID 25600587 DOI: 10.1007/s00204-014-1419-z  0.303
2015 Maayah ZH, Abdelhamid G, El-Kadi AO. Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB. Cell Biology and Toxicology. 31: 241-59. PMID 26493311 DOI: 10.1007/s10565-015-9308-7  0.349
2015 Elkhatali S, El-Sherbeni AA, Elshenawy OH, Abdelhamid G, El-Kadi AO. 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy. Toxicology and Applied Pharmacology. 289: 550-9. PMID 26454030 DOI: 10.1016/j.taap.2015.10.003  0.338
2015 Elshenawy OH, El-Kadi AO. Modulation of aryl hydrocarbon receptor-regulated enzymes by trimethylarsine oxide in C57BL/6 mice: In vivo and in vitro studies. Toxicology Letters. 238: 17-31. PMID 26144063 DOI: 10.1016/j.toxlet.2015.06.1646  0.471
2015 Elshenawy OH, El-Kadi AO. Modulation of aryl hydrocarbon receptor regulated genes by acute administration of trimethylarsine oxide in the lung, kidney and heart of C57BL/6 mice. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 45: 930-43. PMID 26042454 DOI: 10.3109/00498254.2015.1032385  0.441
2015 Althurwi HN, Maayah ZH, Elshenawy OH, El-Kadi AO. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 1254-66. PMID 26033621 DOI: 10.1124/dmd.115.063776  0.451
2015 Abdelhamid G, El-Kadi AO. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways. Free Radical Biology & Medicine. 82: 1-12. PMID 25614461 DOI: 10.1016/j.freeradbiomed.2015.01.005  0.371
2015 Maayah ZH, Elshenawy OH, Althurwi HN, Abdelhamid G, El-Kadi AO. Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites. Journal of Pharmacological and Toxicological Methods. 71: 33-41. PMID 25454080 DOI: 10.1016/j.vascn.2014.11.005  0.342
2014 El-Sherbeni AA, El-Kadi AO. The role of epoxide hydrolases in health and disease. Archives of Toxicology. 88: 2013-32. PMID 25248500 DOI: 10.1007/s00204-014-1371-y  0.333
2014 Anwar-Mohamed A, Elshenawy OH, El-Sherbeni AA, Abdelrady M, El-Kadi AO. Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl/6 mice. Canadian Journal of Physiology and Pharmacology. 92: 693-702. PMID 25065748 DOI: 10.1139/cjpp-2014-0136  0.309
2014 El-Sherbeni AA, El-Kadi AO. Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 1498-507. PMID 24969701 DOI: 10.1124/dmd.114.057836  0.43
2014 Amara IE, Elshenawy OH, Abdelrady M, El-Kadi AO. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart. Toxicology Letters. 226: 53-62. PMID 24472606 DOI: 10.1016/j.toxlet.2014.01.025  0.846
2014 El-Sherbeni AA, El-Kadi AO. Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy. Biochemical Pharmacology. 87: 456-66. PMID 24300133 DOI: 10.1016/j.bcp.2013.11.015  0.421
2014 Anwar-Mohamed A, Elshenawy OH, Soshilov AA, Denison MS, Chris Le X, Klotz LO, El-Kadi AO. Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms. Free Radical Biology & Medicine. 67: 171-87. PMID 24161444 DOI: 10.1016/J.Freeradbiomed.2013.10.810  0.435
2014 Althurwi HN, Elshenawy OH, El-Kadi AO. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy. Journal of Cardiovascular Pharmacology. 63: 167-77. PMID 24157956 DOI: 10.1097/FJC.0000000000000036  0.441
2013 Gordon M, El-Kalla M, Zhao Y, Fiteih Y, Law J, Volodko N, Anwar-Mohamed A, Mohamed A, El-Kadi AO, Liu L, Odenbach J, Thiesen A, Onyskiw C, Ghazaleh HA, Park J, et al. The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury. Plos One. 8: e75483. PMID 24146755 DOI: 10.1371/Journal.Pone.0075483  0.319
2013 Elshenawy OH, Anwar-Mohamed A, El-Kadi AO. 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. Current Drug Metabolism. 14: 706-19. PMID 23701160  0.305
2013 Alsaad AM, Zordoky BN, Tse MM, El-Kadi AO. Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. Drug Metabolism Reviews. 45: 173-95. PMID 23600686 DOI: 10.3109/03602532.2012.754460  0.696
2013 Amara IE, Anwar-Mohamed A, El-Kadi AO. Posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by methylmercury in HepG2 cells: a role of heme oxygenase-1. Toxicology Letters. 219: 239-47. PMID 23541843 DOI: 10.1016/j.toxlet.2013.03.018  0.829
2013 El Gendy MA, El-Kadi AO. Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL/6 mice. Biomed Research International. 2013: 258095. PMID 23509697 DOI: 10.1155/2013/258095  0.386
2013 Tse MM, Aboutabl ME, Althurwi HN, Elshenawy OH, Abdelhamid G, El-Kadi AO. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line. Vascular Pharmacology. 58: 363-73. PMID 23466634 DOI: 10.1016/J.Vph.2013.02.004  0.784
2013 Abdelhamid G, Amara IE, Anwar-Mohamed A, El-Kadi AO. Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice. Archives of Toxicology. 87: 1531-43. PMID 23423713 DOI: 10.1007/s00204-013-1023-7  0.809
2013 Anwar-Mohamed A, El-Sherbeni A, Kim SH, Elshenawy OH, Althurwi HN, Zordoky BN, El-Kadi AO. Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl/6 mice. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 43: 719-29. PMID 23409951 DOI: 10.3109/00498254.2012.754113  0.722
2013 Ansari MA, Maayah ZH, Bakheet SA, El-Kadi AO, Korashy HM. The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model. Toxicology. 306: 40-9. PMID 23391631 DOI: 10.1016/J.Tox.2013.01.024  0.406
2013 Anwar-Mohamed A, Abdelhamid G, Amara IE, El-Kadi AO. Differential modulation of cytochrome P450 1a1 by arsenite in vivo and in vitro in C57BL/6 mice. Free Radical Biology & Medicine. 58: 52-63. PMID 23369756 DOI: 10.1016/j.freeradbiomed.2013.01.012  0.82
2013 Maayah ZH, El Gendy MA, El-Kadi AO, Korashy HM. Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation. Archives of Toxicology. 87: 847-56. PMID 23288144 DOI: 10.1007/s00204-012-0996-y  0.384
2013 Elshenawy OH, Anwar-Mohamed A, Abdelhamid G, El-Kadi AO. Murine atrial HL-1 cell line is a reliable model to study drug metabolizing enzymes in the heart. Vascular Pharmacology. 58: 326-33. PMID 23268359 DOI: 10.1016/j.vph.2012.12.002  0.464
2013 Amara IE, Anwar-Mohamed A, Abdelhamid G, El-Kadi AO. Mercury modulates the cytochrome P450 1a1, 1a2 and 1b1 in C57BL/6J mice: in vivo and in vitro studies. Toxicology and Applied Pharmacology. 266: 419-29. PMID 23231920 DOI: 10.1016/j.taap.2012.11.027  0.818
2013 Althurwi HN, Tse MM, Abdelhamid G, Zordoky BN, Hammock BD, El-Kadi AO. Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy. British Journal of Pharmacology. 168: 1794-807. PMID 23176298 DOI: 10.1111/Bph.12066  0.72
2013 El-Sherbeni AA, Aboutabl ME, Zordoky BN, Anwar-Mohamed A, El-Kadi AO. Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics. The Aaps Journal. 15: 112-22. PMID 23139020 DOI: 10.1208/S12248-012-9425-7  0.82
2013 Brocks DR, Hamdy DA, Ben-Eltriki M, Patel JP, El-Kadi AOS. Effect of rat serum lipoproteins on mRNA levels and amiodarone metabolism by cultured primary rat hepatocytes Journal of Pharmaceutical Sciences. 102: 262-270. PMID 23132435 DOI: 10.1002/jps.23348  0.327
2013 Chaudhary KR, Zordoky BN, Edin ML, Alsaleh N, El-Kadi AO, Zeldin DC, Seubert JM. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice. Prostaglandins & Other Lipid Mediators. 104: 8-17. PMID 22922020 DOI: 10.1016/j.prostaglandins.2012.08.001  0.665
2013 Abdelhamid G, Amara IE, Anwar-Mohamed A, El-Kadi AO. Modulation of aryl hydrocarbon receptor-regulated genes by acute administration of ammonium metavanadate in kidney, lung and heart of C57BL/6 mice. Journal of Applied Toxicology : Jat. 33: 1230-40. PMID 22611038 DOI: 10.1002/jat.2774  0.833
2012 Hanafy S, El-Kadi AO, Jamali F. Effect of inflammation on molecular targets and drug transporters. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 15: 361-75. PMID 22974786  0.328
2012 Alsaad AM, Zordoky BN, El-Sherbeni AA, El-Kadi AO. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 2126-35. PMID 22867862 DOI: 10.1124/dmd.112.046631  0.774
2012 Anwar-Mohamed A, El-Sherbeni AA, Kim SH, Althurwi HN, Zordoky BN, El-Kadi AO. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 42: 1235-47. PMID 22680237 DOI: 10.3109/00498254.2012.693971  0.779
2012 Amara IE, Anwar-Mohamed A, Abdelhamid G, El-Kadi AO. Effect of mercury on aryl hydrocarbon receptor-regulated genes in the extrahepatic tissues of C57BL/6 mice. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 50: 2325-34. PMID 22579925 DOI: 10.1016/j.fct.2012.04.028  0.82
2012 Korashy HM, El Gendy MA, Alhaider AA, El-Kadi AO. Camel milk modulates the expression of aryl hydrocarbon receptor-regulated genes, Cyp1a1, Nqo1, and Gsta1, in murine hepatoma Hepa 1c1c7 cells. Journal of Biomedicine & Biotechnology. 2012: 782642. PMID 22570534 DOI: 10.1155/2012/782642  0.412
2012 Anwar-Mohamed A, Abdelhamid G, Amara IE, El-Kadi AO. Differential modulation of aryl hydrocarbon receptor regulated enzymes by arsenite in the kidney, lung, and heart of C57BL/6 mice. Archives of Toxicology. 86: 897-910. PMID 22535251 DOI: 10.1007/s00204-012-0855-x  0.825
2012 Anwar-Mohamed A, Klotz LO, El-Kadi AO. Inhibition of heme oxygenase-1 partially reverses the arsenite-mediated decrease of CYP1A1, CYP1A2, CYP3A23, and CYP3A2 catalytic activity in isolated rat hepatocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 504-14. PMID 22159698 DOI: 10.1124/dmd.111.042564  0.47
2012 Korashy HM, El-Kadi AO. Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase. Toxicology. 291: 113-21. PMID 22120038 DOI: 10.1016/j.tox.2011.11.006  0.473
2012 El Gendy MA, Soshilov AA, Denison MS, El-Kadi AO. Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 50: 353-62. PMID 22037238 DOI: 10.1016/J.Fct.2011.10.052  0.404
2012 El Gendy MA, Soshilov AA, Denison MS, El-Kadi AO. Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol. Toxicology Letters. 208: 51-61. PMID 22001777 DOI: 10.1016/J.Toxlet.2011.09.030  0.424
2011 Amara IE, El-Kadi AO. Transcriptional modulation of the NAD(P)H:quinone oxidoreductase 1 by mercury in human hepatoma HepG2 cells. Free Radical Biology & Medicine. 51: 1675-85. PMID 21843634 DOI: 10.1016/j.freeradbiomed.2011.07.021  0.828
2011 Korashy HM, Anwar-Mohamed A, Soshilov AA, Denison MS, El-Kadi AO. The p38 MAPK inhibitor SB203580 induces cytochrome P450 1A1 gene expression in murine and human hepatoma cell lines through ligand-dependent aryl hydrocarbon receptor activation. Chemical Research in Toxicology. 24: 1540-8. PMID 21732638 DOI: 10.1021/Tx200141P  0.459
2011 Zordoky BN, Anwar-Mohamed A, Aboutabl ME, El-Kadi AO. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 1440-50. PMID 21571947 DOI: 10.1124/Dmd.111.039123  0.83
2011 Aboutabl ME, Zordoky BN, Hammock BD, El-Kadi AO. Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene. Journal of Cardiovascular Pharmacology. 57: 273-81. PMID 21383588 DOI: 10.1097/Fjc.0B013E3182055Baf  0.822
2011 Anwar-Mohamed A, Degenhardt OS, El Gendy MA, Seubert JM, Kleeberger SR, El-Kadi AO. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers. Toxicology in Vitro : An International Journal Published in Association With Bibra. 25: 785-95. PMID 21281708 DOI: 10.1016/j.tiv.2011.01.014  0.338
2011 Alhaider AA, El Gendy MA, Korashy HM, El-Kadi AO. Camel urine inhibits the cytochrome P450 1a1 gene expression through an AhR-dependent mechanism in Hepa 1c1c7 cell line. Journal of Ethnopharmacology. 133: 184-90. PMID 20883769 DOI: 10.1016/j.jep.2010.09.012  0.305
2010 Amara IE, Anwar-Mohamed A, El-Kadi AO. Mercury modulates the CYP1A1 at transcriptional and posttranslational levels in human hepatoma HepG2 cells. Toxicology Letters. 199: 225-33. PMID 20837117 DOI: 10.1016/j.toxlet.2010.09.003  0.829
2010 El Gendy MA, El-Kadi AO. Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism. Toxicology and Applied Pharmacology. 249: 55-64. PMID 20732341 DOI: 10.1016/j.taap.2010.08.014  0.448
2010 Abdelhamid G, Anwar-Mohamed A, Elmazar MM, El-Kadi AO. Modulation of NAD(P)H:quinone oxidoreductase by vanadium in human hepatoma HepG2 cells. Toxicology in Vitro : An International Journal Published in Association With Bibra. 24: 1554-61. PMID 20599494 DOI: 10.1016/j.tiv.2010.06.017  0.364
2010 Elsherbiny ME, El-Kadi AO, Brocks DR. The effect of beta-naphthoflavone on the metabolism of amiodarone by hepatic and extra-hepatic microsomes. Toxicology Letters. 195: 147-54. PMID 20362646 DOI: 10.1016/j.toxlet.2010.03.019  0.366
2010 Abdelhamid G, Anwar-Mohamed A, Badary OA, Moustafa AA, El-Kadi AO. Transcriptional and posttranscriptional regulation of CYP1A1 by vanadium in human hepatoma HepG2 cells. Cell Biology and Toxicology. 26: 421-34. PMID 20221682 DOI: 10.1007/s10565-010-9153-7  0.406
2010 Anwar-Mohamed A, El-Kadi AO. Arsenite down-regulates cytochrome P450 1A1 at the transcriptional and posttranslational levels in human HepG2 cells. Free Radical Biology & Medicine. 48: 1399-409. PMID 20188822 DOI: 10.1016/j.freeradbiomed.2010.02.027  0.453
2010 Zordoky BN, El-Kadi AO. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacology & Therapeutics. 125: 446-63. PMID 20093140 DOI: 10.1016/j.pharmthera.2009.12.002  0.69
2010 Anwar-mohamed A, Zordoky BN, Aboutabl ME, El-Kadi AO. Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation. Pharmacological Research. 61: 410-8. PMID 20045729 DOI: 10.1016/J.Phrs.2009.12.015  0.837
2010 Zordoky BN, El-Kadi AO. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism. Toxicology in Vitro : An International Journal Published in Association With Bibra. 24: 863-71. PMID 19969063 DOI: 10.1016/j.tiv.2009.12.002  0.722
2010 El Gendy MA, Somayaji V, El-Kadi AO. Peganum harmala L. is a candidate herbal plant for preventing dioxin mediated effects. Planta Medica. 76: 671-7. PMID 19941261 DOI: 10.1055/s-0029-1240633  0.342
2010 Zordoky BN, Anwar-Mohamed A, Aboutabl ME, El-Kadi AO. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicology and Applied Pharmacology. 242: 38-46. PMID 19796650 DOI: 10.1016/J.Taap.2009.09.012  0.835
2010 Anwar-Mohamed A, El-Kadi AO. Inhibition of Heme Oxygenase-1 Partially Reverses the Arsenite-mediated Decrease of Cytochrome P450 1A1 (CYP1A1), CYP1A2, CYP3A23, and CYP3A2 Catalytic Activity in Isolated Rat Hepatocytes Free Radical Biology and Medicine. 49: S87. DOI: 10.1016/j.freeradbiomed.2010.10.219  0.353
2010 Zordoky B, El-Kadi A. Acute Doxorubicin Toxicity Differentially Alters Cytochrome P450 Expression in the Kidney and Liver of Male Sprague Dawley Rats Free Radical Biology and Medicine. 49: S75. DOI: 10.1016/J.Freeradbiomed.2010.10.187  0.718
2009 El Gendy MA, El-Kadi AO. Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells. Drug Metabolism Letters. 3: 212-6. PMID 20041830  0.332
2009 Aboutabl ME, Zordoky BN, El-Kadi AO. 3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats. British Journal of Pharmacology. 158: 1808-19. PMID 19889059 DOI: 10.1111/J.1476-5381.2009.00461.X  0.814
2009 Anwar-Mohamed A, El-Kadi AO. Down-regulation of the detoxifying enzyme NAD(P)H:quinone oxidoreductase 1 by vanadium in Hepa 1c1c7 cells. Toxicology and Applied Pharmacology. 236: 261-9. PMID 19367690  0.403
2009 Zordoky BN, El-Kadi AO. Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Current Drug Metabolism. 10: 164-78. PMID 19275551 DOI: 10.2174/138920009787522151  0.684
2009 Anwar-Mohamed A, El-Kadi AO. Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells. Cancer Letters. 275: 93-101. PMID 19013013 DOI: 10.1016/j.canlet.2008.10.003  0.435
2008 Anwar-Mohamed A, Elbekai RH, El-Kadi AO. MG-132 inhibits the TCDD-mediated induction of Cyp1a1 at the catalytic activity but not the mRNA or protein levels in Hepa 1c1c7 cells. Toxicology Letters. 182: 121-6. PMID 18835339 DOI: 10.1016/j.toxlet.2008.09.007  0.386
2008 Zordoky BN, Aboutabl ME, El-Kadi AO. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 2277-86. PMID 18725507 DOI: 10.1124/Dmd.108.023077  0.838
2008 Zordoky BN, El-Kadi AO. Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells. Vascular Pharmacology. 49: 166-72. PMID 18707023 DOI: 10.1016/j.vph.2008.07.004  0.733
2008 Shayeganpour A, Korashy H, Patel JP, El-Kadi AO, Brocks DR. The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat. International Journal of Pharmaceutics. 361: 78-86. PMID 18599227 DOI: 10.1016/j.ijpharm.2008.05.019  0.311
2008 Anwar-Mohamed A, El-Kadi AO. Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1819-27. PMID 18541696 DOI: 10.1124/dmd.108.021154  0.414
2008 Elbekai RH, El-Kadi AO. Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications. Toxicology in Vitro : An International Journal Published in Association With Bibra. 22: 1184-90. PMID 18474416 DOI: 10.1016/j.tiv.2008.03.010  0.334
2008 Zordoky BN, El-Kadi AO. Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure. Current Drug Metabolism. 9: 122-8. PMID 18288954  0.708
2008 Korashy HM, El-Kadi AO. The role of redox-sensitive transcription factors NF-kappaB and AP-1 in the modulation of the Cyp1a1 gene by mercury, lead, and copper. Free Radical Biology & Medicine. 44: 795-806. PMID 18078826 DOI: 10.1016/j.freeradbiomed.2007.11.003  0.305
2007 Korashy HM, Brocks DR, El-Kadi AO. Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: a mechanism of cancer chemoprotection. Cancer Letters. 258: 135-43. PMID 17923278 DOI: 10.1016/j.canlet.2007.08.016  0.382
2007 Aboutabl ME, El-Kadi AO. Constitutive expression and inducibility of CYP1A1 in the H9c2 rat cardiomyoblast cells. Toxicology in Vitro : An International Journal Published in Association With Bibra. 21: 1686-91. PMID 17719738 DOI: 10.1016/J.Tiv.2007.07.002  0.779
2007 Zordoky BN, El-Kadi AO. H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart. Journal of Pharmacological and Toxicological Methods. 56: 317-22. PMID 17662623 DOI: 10.1016/j.vascn.2007.06.001  0.673
2007 Elbekai RH, El-Kadi AO. Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. Toxicology Letters. 172: 106-19. PMID 17606337 DOI: 10.1016/j.toxlet.2007.05.009  0.342
2007 Anwar-Mohamed A, El-Kadi AO. Induction of cytochrome P450 1a1 by the food flavoring agent, maltol. Toxicology in Vitro : An International Journal Published in Association With Bibra. 21: 685-90. PMID 17317091 DOI: 10.1016/j.tiv.2007.01.003  0.391
2007 Korashy HM, Shayeganpour A, Brocks DR, El-Kadi AO. Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines. Toxicological Sciences : An Official Journal of the Society of Toxicology. 97: 32-43. PMID 17283379 DOI: 10.1093/toxsci/kfm012  0.4
2007 Elbekai RH, Duke J, El-Kadi AO. Ascorbic acid differentially modulates the induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase Ya by As(3+), Cd(2+) and Cr(6+). Cancer Letters. 246: 54-62. PMID 16517059 DOI: 10.1016/j.canlet.2006.01.029  0.383
2006 Korashy HM, El-Kadi AO. The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug Metabolism Reviews. 38: 411-50. PMID 16877260 DOI: 10.1080/03602530600632063  0.38
2006 Elbekai RH, El-Kadi AO. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacology & Therapeutics. 112: 564-87. PMID 16824612 DOI: 10.1016/j.pharmthera.2005.05.011  0.304
2006 Korashy HM, El-Kadi AO. Transcriptional regulation of the NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase ya genes by mercury, lead, and copper. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 152-65. PMID 16243960 DOI: 10.1124/dmd.105.005397  0.372
2006 Shayeganpour A, El-Kadi AO, Brocks DR. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 43-50. PMID 16204463 DOI: 10.1124/dmd.105.006742  0.345
2005 Elbekai RH, El-Kadi AO. The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+. Free Radical Biology & Medicine. 39: 1499-511. PMID 16274885 DOI: 10.1016/j.freeradbiomed.2005.07.012  0.335
2005 Korashy HM, El-Kadi AO. Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals. Toxicological Sciences : An Official Journal of the Society of Toxicology. 88: 39-51. PMID 16093525 DOI: 10.1093/toxsci/kfi282  0.335
2005 Gharavi N, El-Kadi AO. tert-Butylhydroquinone is a novel aryl hydrocarbon receptor ligand. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 365-72. PMID 15608132 DOI: 10.1124/dmd.104.002253  0.427
2004 Elbekai RH, Korashy HM, Wills K, Gharavi N, El-Kadi AO. Benzo[a]pyrene, 3-methylcholanthrene and beta-naphthoflavone induce oxidative stress in hepatoma hepa 1c1c7 Cells by an AHR-dependent pathway. Free Radical Research. 38: 1191-200. PMID 15621696 DOI: 10.1080/10715760400017319  0.318
2004 Elbekai RH, El-Kadi AO. Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium. Toxicology. 202: 249-69. PMID 15337587 DOI: 10.1016/j.tox.2004.05.009  0.323
2004 Korashy HM, El-Kadi AO. Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells. Toxicology. 201: 153-72. PMID 15297030 DOI: 10.1016/j.tox.2004.04.011  0.351
2001 Barakat MM, El-Kadi AO, du Souich P. L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction. Life Sciences. 69: 1559-71. PMID 11554617 DOI: 10.1016/S0024-3205(01)01241-3  0.528
Show low-probability matches.